LabCorp (LH)
| Market Cap | 27.17B |
| Revenue (ttm) | 15.32B |
| Net Income (ttm) | 2.64B |
| Shares Out | 97.60M |
| EPS (ttm) | 26.89 |
| PE Ratio | 10.34 |
| Forward PE | 12.71 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | May 7 |
| Last Price | $278.14 |
| Previous Close | $278.08 |
| Change ($) | 0.06 |
| Change (%) | 0.02% |
| Day's Open | 278.11 |
| Day's Range | 276.94 - 280.73 |
| Day's Volume | 483,890 |
| 52-Week Range | 155.19 - 280.73 |
LabCorp's (LH) Walgreens-partnership expands to include new integrated digital experiences.
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has entered into a definitive agreement to acquire select operating assets and inte...
Test Available Exclusively through Labcorp in the U.S. and Canada
LabCorp's (LH) raises 2021 guidance but projects significant sinking of COVID-related testing revenues.
LabCorp (LH) delivered earnings and revenue surprises of 20.08% and 7.39%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading life sciences company, today announced results for the first quarter ended March 31, 2021 and raised 2021 guidance. “We delivered very st...
LabCorp (LH) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
With respect to LabCorp's (LH) COVID-19 testing services wing, although extensive vaccine rollouts are ongoing, the resurgence of the virus might have once again boosted testing demand in Q1.
LabCorp (LH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
LabCorp (LH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced the availability of the Pixel by Labcorp® COVID-19 PCR Test Home Collection Kit for small b...
Investors are optimistic about LabCorp (LH) backed by its strong diagnostic arm growth and progress in Covance business.
When screening the market for value opportunities, one method is to pick stocks whose trailing 12-month price-to-free cash flow ratios are low compared to that of the S&P 500 Index, which stands at arou...
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced that its Annual Meeting of Shareholders will be webcast live beginning May 12, at 9:00 a.m....
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, will release its first quarter of 2021 financial results before the market opens on Thursday, April 29, 202...
There are investors who believe growth is very important as long as you do not pay too much for it. Such investors are looking for the union of growth and value in stocks when screening the market.
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced the appointment of Kathryn Wengel, current Executive Vice President and Chief Global Supply...
Coronavirus testing play Laboratory Corporation of America is offering up a new buying opportunity. LH stock has run as much as 160% above its 2020 lows.
LabCorp (LH) plays a critical role in terms of COVID-19-related developments as well as makes progress in other key therapeutic areas.
LabCorp (LH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down t...
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today issued its 2019-2020 Corporate Responsibility Report: Making a Difference When It Counts. The report ...
Yesterday was a rough day for risk assets after Germany announced an Easter lockdown to avoid a new acceleration in Covid-19 cases and deaths. The measures are a response to recent worrying signs of tro...
Since the market bottomed out exactly a year ago amid the Covid-19 pandemic, conditions have begun to improve as the vaccine distribution continues.
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading life sciences company, today issued the following statement: Labcorp continues to make progress executing our strategy and capitalizing o...
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced that Marcia Eisenberg, Ph.D., chief scientific officer of Labcorp Diagnostics, was recogniz...
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced that members of the executive management team will participate in a virtual fireside chat a...
SAN FRANCISCO--(BUSINESS WIRE)--Circle Medical, a digital-first primary care practice, will be offering a convenient at home COVID-19 self-collection test kit in partnership with Labcorp (NYSE: LH). Tog...
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has been named to Fast Company magazine's list of 2021 Most Innovative Companies. S...
On Wednesday, Laboratory Corporation Of America got an upgrade for its IBD SmartSelect Composite Rating from 94 to 96. The post Covid Test Firm Labcorp Joins Elite List Of Stocks With 95-Plus Composite ...
CARDIFF, Wales--(BUSINESS WIRE)--TrakCel, a leading supplier of cellular orchestration solutions supporting the cell and gene therapy industry, today announces that it has closed its latest funding roun...
Jana Partners (Trades, Portfolio), a New York-based investment firm, disclosed last week that its top four trades during the fourth quarter of 2020 featured new holdings in Laboratory Corp of America Ho...
DEERFIELD, Ill. & BURLINGTON, N.C.--(BUSINESS WIRE)--As part of Walgreens ongoing efforts to increase access to COVID-19 testing in communities across the U.S., the company announced today it has entere...
Pacific Biosciences' (PACB) Sequel II HiFi sequencing gets utilized by LabCorp to detect SARS-COV-2 variants in the United States.
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced that members of the executive management team will participate in a virtual fireside chat a...
LabCorp's (LH) new antigen test is the newest development to detect COVID-19 infection at every single stage, from diagnostic testing to vaccination trails.
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced the availability of a new laboratory-based antigen test that will help doctors determine if...
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced that Amy Summy, executive vice president and chief marketing officer, was recognized on the...
The laboratory services giant continued to profit mightily from its COVID-19 testing business.
LabCorp's (LH) 2021 guidance projects significant downfall in COVID-related testing revenues.
LabCorp (LH) delivered earnings and revenue surprises of 31.18% and 12.94%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading life sciences company, today announced results for the fourth quarter and year ended December 31, 2020, and full year 2021 guidance. “Lab...
LabCorp (LH) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced the appointments of Prasanth Reddy, MD, MPH, and Robert Phillips, PhD, to its oncology team...
LabCorp's (LH) fourth-quarter base-business performance is expected to have registered slower recovery rate compared to the third quarter.
LabCorp is benefitting from the recent surge in COVID infections, and the new COVID variants should keep up demand for its services. It continues to build its healthcare footprint and expand its moat.
About LH
Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C and vitamin D products, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company also provides ... [Read more...]
| Industry Diagnostics & Research | Founded 1971 |
| CEO Adam Schechter | Employees 70,000 |
| Stock Exchange NYSE | Ticker Symbol LH |
Financial Performance
In 2020, LabCorp's revenue was $13.98 billion, an increase of 20.98% compared to the previous year's $11.55 billion. Earnings were $1.56 billion, an increase of 88.89%.
Analyst Forecasts
According to 18 analysts, the average rating for LabCorp stock is "Buy." The 12-month stock price forecast is 295.85, which is an increase of 6.37% from the latest price.